Townsquare Capital LLC Acquires 6,249 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)

Townsquare Capital LLC increased its holdings in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) by 8.8% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 77,168 shares of the company’s stock after acquiring an additional 6,249 shares during the period. Townsquare Capital LLC owned about 0.16% of Prestige Consumer Healthcare worth $5,564,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of PBH. Bayesian Capital Management LP acquired a new position in Prestige Consumer Healthcare during the 1st quarter worth $213,000. Tidal Investments LLC lifted its holdings in Prestige Consumer Healthcare by 4.7% during the 1st quarter. Tidal Investments LLC now owns 5,748 shares of the company’s stock worth $417,000 after buying an additional 256 shares in the last quarter. Atria Investments Inc acquired a new position in Prestige Consumer Healthcare during the 1st quarter worth $1,246,000. EverSource Wealth Advisors LLC lifted its holdings in Prestige Consumer Healthcare by 80.6% during the 1st quarter. EverSource Wealth Advisors LLC now owns 466 shares of the company’s stock worth $33,000 after buying an additional 208 shares in the last quarter. Finally, GAMMA Investing LLC lifted its holdings in Prestige Consumer Healthcare by 51.3% during the 2nd quarter. GAMMA Investing LLC now owns 776 shares of the company’s stock worth $53,000 after buying an additional 263 shares in the last quarter. Institutional investors and hedge funds own 99.95% of the company’s stock.

Analysts Set New Price Targets

PBH has been the topic of several research reports. Jefferies Financial Group reaffirmed a “hold” rating and set a $76.00 price objective (up previously from $70.00) on shares of Prestige Consumer Healthcare in a report on Tuesday, September 24th. DA Davidson reissued a “buy” rating and issued a $95.00 price target on shares of Prestige Consumer Healthcare in a research note on Monday, November 11th. One analyst has rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $83.67.

Prestige Consumer Healthcare Stock Performance

Shares of Prestige Consumer Healthcare stock opened at $84.17 on Friday. The company has a market capitalization of $4.16 billion, a PE ratio of 20.48, a PEG ratio of 2.38 and a beta of 0.47. Prestige Consumer Healthcare Inc. has a 12 month low of $56.61 and a 12 month high of $86.36. The company has a current ratio of 3.56, a quick ratio of 2.10 and a debt-to-equity ratio of 0.61. The stock’s fifty day simple moving average is $75.17 and its 200 day simple moving average is $71.06.

Prestige Consumer Healthcare (NYSE:PBH) last issued its quarterly earnings data on Thursday, November 7th. The company reported $1.09 EPS for the quarter, hitting the consensus estimate of $1.09. The business had revenue of $283.79 million for the quarter, compared to the consensus estimate of $282.09 million. Prestige Consumer Healthcare had a return on equity of 12.23% and a net margin of 18.54%. The firm’s revenue was down .9% compared to the same quarter last year. During the same quarter last year, the business posted $1.07 EPS. On average, research analysts predict that Prestige Consumer Healthcare Inc. will post 4.45 EPS for the current year.

Insiders Place Their Bets

In other Prestige Consumer Healthcare news, CEO Ronald M. Lombardi sold 10,875 shares of the stock in a transaction dated Tuesday, November 19th. The stock was sold at an average price of $82.60, for a total transaction of $898,275.00. Following the completion of the transaction, the chief executive officer now owns 320,952 shares in the company, valued at approximately $26,510,635.20. This represents a 3.28 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Adel Mekhail sold 9,063 shares of the stock in a transaction dated Tuesday, November 12th. The stock was sold at an average price of $82.00, for a total value of $743,166.00. Following the transaction, the executive vice president now owns 18,365 shares of the company’s stock, valued at approximately $1,505,930. This trade represents a 33.04 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 38,810 shares of company stock worth $3,187,300. Corporate insiders own 1.60% of the company’s stock.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.